LIPOSOMAL BUPIVACAINE PLUS BUPIVACAINE VERSUS BUPIVACAINE HCL FOR INTERSCALENE BRACHIAL PLEXUS BLOCK IN PATIENTS UNDERGOING TOTAL SHOULDER ARTHROPLASTY

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Total Shoulder Arthroplasty
  • Age: Between 18 - 75 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Subjects are between 18 and 75 years of age
    2. Subjects who are undergoing total shoulder arthroplasty
    3. Subjects who consent to be randomized.

You may not be eligible for this study if the following are true:

    1. Subjects who are younger than 18 and older than 75
    2. Subjects with a history of chronic pain that have used opioids for pain management for 3 months or longer
    3. Subjects who are allergic to oxycodone
    4. Subjects who are unable to speak English
    5. Subjects with diagnosed or self-reported cognitive dysfunction
    6. Subjects with a history of neurologic disorder that can interfere with pain sensation
    7. Subjects with a history of drug or recorded alcohol abuse
    8. Subjects who are unable to understand or follow instructions
    9. Subjects with severe liver disease, renal insufficiency, congestive heart failure, and/or significant heart disease
    10. Subjects with an allergy or contraindication to any of the medications used in the study, or patients with a contraindication to any study procedures
    11. Subjects with BMI over 40
    12. Any subjects that the investigators feel cannot comply with all study related procedures
    13. NYU Langone Health students, residents, faculty or staff members



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.